| SKU | ISG007320 |
| Brand | توينزول |
| Categories | Medication & Treatments |
| Shop by Concerns | Elevated Intraocular Pressure |
| Gender | Unisex |
| Shop By Goals | Glaucoma Management |
| Ingredient | Dorzolamide hydrochloride Timolol |
| UPC | 6224000219307 |
| Size | 5 Ml |
| Specialty | Clinically Tested Ophthalmic Use Prescription only |
| Sub Categories | Eye Drops & Lubricants |
| Warning | Keep Out of Reach of Children Do not use for longer than directed by a doctor For ocular use only May cause blurred vision temporarily Use With Caution in Heart Disease Use with caution in respiratory conditions |
Twinzol Eye Drops 5 ml
Description:
Twinzol Eye Drops 5 ml is a prescription ophthalmic medicine combining dorzolamide and timolol, two well-established antiglaucoma agents, used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is formulated as sterile eye drops for topical use in the eye to reduce the risk of optic nerve damage and progressive vision loss by decreasing the production of aqueous humor and thereby reducing intraocular pressure. Manufactured by Orchidia, Twinzol provides dual-mechanism pressure control in a convenient fixed-dose combination.
Indications:
- Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.
- Treatment of ocular hypertension where high eye pressure may lead to glaucoma or optic nerve damage.
- Patients insufficiently controlled with beta-blocker monotherapy or carbonic anhydrase inhibitor monotherapy and who require combination therapy.
- Helps reduce the risk of progressive visual field loss associated with chronically elevated intraocular pressure.
Active Ingredients / Key Components:
- Dorzolamide hydrochloride – concentration in mg/ml is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).
- Timolol maleate – concentration in mg/ml is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.).
- Other excipients (buffering agents, stabilizers, preservatives, purified water) – full excipient list is not available in the provided data.
Dosage & Administration / How to Use:
- Use only as directed by your ophthalmologist or healthcare provider.
- Typical adult dosage (when prescribed as a fixed combination): usually 1 drop in the affected eye(s) twice daily (morning and evening). The exact regimen must be confirmed by the prescribing doctor.
- Wash hands thoroughly before use.
- Shake the bottle gently if instructed on the package insert, then remove the cap without touching the dropper tip.
- Tilt your head back, gently pull down the lower eyelid to form a small pocket, and instill one drop into the conjunctival sac, avoiding contact of the dropper tip with the eye or any surface.
- After instillation, gently close the eye and apply light pressure with a finger to the inner corner of the eye (nasolacrimal occlusion) for 1–2 minutes to reduce systemic absorption.
- If using other ophthalmic medications, leave at least 5–10 minutes between different eye drops. Ointments should be applied last.
- Do not exceed the prescribed dose or frequency. Do not stop treatment abruptly without consulting your doctor, as eye pressure may rise again.
- For contact lens wearers: remove contact lenses before instillation and wait at least 15 minutes before reinserting, especially if the product contains preservatives (information on preservative type is not available).
Clinical Benefits:
- Provides effective reduction of elevated intraocular pressure through dual mechanisms (carbonic anhydrase inhibition and beta-blockade).
- Helps protect the optic nerve and visual field by lowering pressure inside the eye in glaucoma and ocular hypertension.
- Offers convenient fixed-dose combination therapy, potentially improving adherence compared with using two separate eye drops.
- Reduces aqueous humor production, contributing to long-term control of intraocular pressure when used regularly as prescribed.
Warnings & Contraindications:
- Contraindicated in patients with known hypersensitivity to dorzolamide, timolol, other sulfonamides, beta-blockers, or any component of the formulation.
- Contraindicated in patients with bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease (COPD) due to the timolol component.
- Contraindicated in patients with sinus bradycardia, second- or third-degree atrioventricular block, overt cardiac failure, or cardiogenic shock.
- Use with caution in patients with cardiovascular disease, peripheral vascular disease, diabetes mellitus, hyperthyroidism, or a history of severe allergic reactions, as beta-blockers may mask symptoms.
- Use with caution in patients with renal impairment or a history of kidney stones, and in those with a history of sulfonamide hypersensitivity due to the dorzolamide component.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Use only if the potential benefit justifies the potential risk.
- Inform your doctor about all systemic beta-blockers, calcium channel blockers, antiarrhythmics, digitalis, or other antiglaucoma medications you are using to avoid additive effects or interactions.
- May cause transient blurred vision after instillation; do not drive or operate machinery until vision is clear.
- Not intended to diagnose, treat, cure, or prevent any disease outside the approved ophthalmic indications.
- Keep out of reach of children.
- For ophthalmic use only. Do not inject or swallow. Avoid touching the dropper tip to any surface to prevent contamination.
Side Effects:
- Common local side effects may include burning or stinging sensation in the eye, eye irritation, redness, tearing, blurred vision, or foreign body sensation.
- Less common effects may include dry eyes, eyelid inflammation, conjunctivitis, or changes in taste (bitter taste) after instillation.
- Systemic side effects related to timolol (due to absorption) may include slow heart rate, low blood pressure, fatigue, dizziness, shortness of breath, or worsening of asthma/COPD in susceptible individuals.
- Systemic side effects related to dorzolamide may include headache, nausea, or signs of sulfonamide-type reactions (e.g., rash, severe skin reactions) in rare cases.
- Seek immediate medical attention if you experience severe breathing difficulty, chest pain, severe dizziness, fainting, swelling of the face or throat, or signs of a severe allergic reaction.
- If any side effects are persistent, bothersome, or unexpected, contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and excessive heat. Keep the bottle tightly closed when not in use. Do not use after the expiry date printed on the pack. Follow any additional storage instructions on the package insert (e.g., temperature range) if provided. Keep out of reach of children.
Specifications:
- Product type: Ophthalmic antiglaucoma medicine (eye drops).
- Form: Sterile solution for ocular use.
- Volume: 5 ml bottle.
- Route of administration: Topical ocular (eye drops).
- Intended users: Adults and elderly patients as prescribed by an ophthalmologist; pediatric use only under specialist supervision.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
